| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6826064 | Schizophrenia Research | 2013 | 9 Pages |
Abstract
This review indicates that ECT, combined with pharmacotherapy, may be a viable option for a selected group of patients with schizophrenia. In particular, the use of ECT is recommended for drug-resistant patients, for schizophrenic patients with catatonia, aggression or suicidal behavior, and when rapid global improvement and reduction of acute symptomatology are required.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Maurizio Pompili, David Lester, Giovanni Dominici, Lucia Longo, Giulia Marconi, Alberto Forte, Gianluca Serafini, Mario Amore, Paolo Girardi,